Different Effects of Simvastatin and Losartan on Cytokine Levels in Coronary Artery Disease

Author： Sadamatsu Kenji  

Publisher： Adis International

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.6, Iss.3, 2006-01, pp. : 169-175

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Losartan and enalapril both reduce the development of accelerated graft coronary artery disease

By  

Inpharma, Vol. 1, Iss. 1269, 2001-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Genetic Polymorphisms in Cytokine and Adhesion Molecule Genes in Coronary Artery Disease

By Auer J.   Weber T.   Berent R.   Lassnig E.   Lamm G.   Eber B.  

American Journal of PharmacoGenomics, Vol. 3, Iss. 5, 2003-01 ,pp. : 317-328

Adis International

Access to resources Recommend Favorite

Angiotensin II-Receptor Antagonist Losartan Does not Prevent Nitroglycerin Tolerance in Patients with Coronary Artery Disease

By Longobardi Giancarlo   Ferrara Nicola   Leosco Dario   Abete Pasquale   Furgi Giuseppe   Cacciatore Francesco   Corbi Graziamaria   Pescatore Raffaella   Rengo Franco  

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 5, 2004-09 ,pp. : 363-370

Springer Publishing Company

Access to resources Recommend Favorite

Celecoxib: beneficial effects in coronary artery disease

By  

Inpharma, Vol. 1, Iss. 1374, 2003-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Nitric oxide in coronary artery disease: effects of antioxidants

By Tousoulis Dimitris   Antoniades Charalambos   Stefanadis Christodoulos  

European Journal of Clinical Pharmacology, Vol. 62, Iss. 1, 2006-02 ,pp. : 101-107

Springer Publishing Company

Access to resources Recommend Favorite